Cite Filings / PRQR / 0001104659-26-080750
Feed Companies Filings Check
Sign in
F-3

Filing

ProQR Therapeutics N.V. · Filed 2026-07-06 · Acc 0001104659-26-080750

Documents 1

  • F-3 , tm2619566-1_f3.htm

Around this filing

  • 2026-07-13 4 Chief Executive Officer bought 150,000 shares at $1.74 ($261,000)
  • 2026-07-08 4 Chief Executive Officer bought 150,000 shares at $1.59 ($238,500)
  • 2026-07-06 F-3 F-3
  • 2026-06-30 SCHEDULE 13D/A Beneficial Ownership Report
  • 2026-06-30 4/A Options or other derivatives
  • 2026-06-30 4 Director bought 150,000 shares at $1.54 ($231,000)
  • 2025-03-13 F-3 F-3

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading tm2619566-1_f3.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…